Search research articles
Contact Us
Filters
Showing results (101-110 of 131) with videos related to
Page
of 14
Sort By:
Journal of Alzheimer'S Disease : JAD
|
March 23, 2011
Tau transgenic mice as models for cerebrospinal fluid tau biomarkers
Donna M Barten, Gregory W Cadelina, Nina Hoque, et al.
European Journal of Pharmacology
|
July 11, 2017
Synergistic inhibition of Aβ production by combinations of γ-secretase modulators
Alan S Robertson, Lawrence G Iben, Cong Wei, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 12, 2010
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents
Zilun Hu, Xiangjun Jiang, Charles F Albright, et al.
BMC Neuroscience
|
November 9, 2010
Viable mouse gene ablations that robustly alter brain Aβ levels are rare
Jeremy H Toyn, Xu-Alan Lin, Mark W Thompson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2020
Synthesis of functionalized derivatives of the gamma-secretase modulator BMS-932481 and identification of its major metabolite
Yunhui Zhang, Kenneth M Boy, Yong-Jin Wu, et al.
Journal of Medicinal Chemistry
|
August 26, 2016
Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors
Yong-Jin Wu, Jason Guernon, Jianliang Shi, et al.
Nature Methods
|
March 31, 2018
Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo"
Christopher J Wilson, Tim Fennell, Anne Bothmer, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents
Yong-Jin Wu, Jason Guernon, Fukang Yang, et al.
Plos One
|
August 26, 2014
Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease
Paul D Wes, Amy Easton, John Corradi, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE)
Kenneth M Boy, Jason M Guernon, Jianliang Shi, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 131) with videos related to
Sort By:
Page
of 14
Journal of Alzheimer'S Disease : JAD
|
March 23, 2011
Tau transgenic mice as models for cerebrospinal fluid tau biomarkers
Donna M Barten, Gregory W Cadelina, Nina Hoque, et al.
European Journal of Pharmacology
|
July 11, 2017
Synergistic inhibition of Aβ production by combinations of γ-secretase modulators
Alan S Robertson, Lawrence G Iben, Cong Wei, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 12, 2010
Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents
Zilun Hu, Xiangjun Jiang, Charles F Albright, et al.
BMC Neuroscience
|
November 9, 2010
Viable mouse gene ablations that robustly alter brain Aβ levels are rare
Jeremy H Toyn, Xu-Alan Lin, Mark W Thompson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2020
Synthesis of functionalized derivatives of the gamma-secretase modulator BMS-932481 and identification of its major metabolite
Yunhui Zhang, Kenneth M Boy, Yong-Jin Wu, et al.
Journal of Medicinal Chemistry
|
August 26, 2016
Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors
Yong-Jin Wu, Jason Guernon, Jianliang Shi, et al.
Nature Methods
|
March 31, 2018
Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo"
Christopher J Wilson, Tim Fennell, Anne Bothmer, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents
Yong-Jin Wu, Jason Guernon, Fukang Yang, et al.
Plos One
|
August 26, 2014
Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease
Paul D Wes, Amy Easton, John Corradi, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE)
Kenneth M Boy, Jason M Guernon, Jianliang Shi, et al.
Page
of 14